Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MARCHINI, Julio F. | |
dc.contributor.author | MIYAKAWA, Ayumi Aurea | |
dc.contributor.author | TARASOUTCHI, Flavio | |
dc.contributor.author | KRIEGER, Jose Eduardo | |
dc.contributor.author | LEMOS, Pedro | |
dc.contributor.author | CROCE, Kevin | |
dc.date.accessioned | 2016-12-20T16:36:25Z | |
dc.date.available | 2016-12-20T16:36:25Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Background: Patients with severe aortic stenosis have increased levels of prothrombotic and proinflammatory microparticles (MP), and MPs actively regulate pathological processes that lead to atherothrombotic cardiovascular events. Shear stress is a validated stimulus of MP production, and abnormal shear stress in aortic stenosis increases MP release in ex-vivo studies. We hypothesized that in patients with severe aortic stenosis, percutaneous replacement of the aortic valve (TAVR) would reduce abnormal shear stress and would decrease levels of circulating MPs. Findings: The experimental protocol utilized flow cytometry (FC) and nanoparticle tracking analysis (NTA) to quantify circulating plasma MP levels in aortic stenosis patients at baseline and 5 days after TAVR. The baseline and 5 day MP counts measured by FC were 6.10.10(5) +/- 1.21.10(5) MP/mu L and 5.74.10(5) +/- 9.54.10(4) MP/mu L, respectively (p = 0.91). The baseline and 5 day MP counts measured by NTA were 9.29.10(13) +/- 1.66.10(13) MP/mu L and 3.95.10(14) +/- 3.11.10(14) MP/mu L, respectively (p = 0.91). When MPs were stratified by cell source, there was no difference in pre/post TAVR endothelial, platelet, or leukocyte MP levels. Conclusion: Levels of circulating MPs do not change acutely following TAVR therapy for aortic stenosis. Trial registered at clinicaltrials. gov NCT02193035 on July 11, 2014. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BR) | |
dc.identifier.citation | JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, v.15, article ID 7, 5p, 2016 | |
dc.identifier.doi | 10.1186/s12952-016-0051-2 | |
dc.identifier.issn | 1477-5751 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/17030 | |
dc.language.iso | eng | |
dc.publisher | BIOMED CENTRAL LTD | |
dc.relation.ispartof | Journal of Negative Results in Biomedicine | |
dc.rights | openAccess | |
dc.rights.holder | Copyright BIOMED CENTRAL LTD | |
dc.subject | Severe aortic stenosis | |
dc.subject | Microparticles | |
dc.subject | Nanoparticle-tracking analysis | |
dc.subject | Flow cytometry | |
dc.subject.other | nanoparticle tracking analysis | |
dc.subject.other | circulating microparticles | |
dc.subject.other | activation | |
dc.subject.other | vesicles | |
dc.subject.other | exosomes | |
dc.subject.other | cells | |
dc.subject.wos | Medicine, Research & Experimental | |
dc.title | Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.author.external | CROCE, Kevin:Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA USA | |
hcfmusp.citation.scopus | 7 | |
hcfmusp.contributor.author-fmusphc | JULIO FLAVIO MEIRELLES MARCHINI | |
hcfmusp.contributor.author-fmusphc | AYUMI AUREA MIYAKAWA YAMAGUCHI | |
hcfmusp.contributor.author-fmusphc | FLAVIO TARASOUTCHI | |
hcfmusp.contributor.author-fmusphc | JOSE EDUARDO KRIEGER | |
hcfmusp.contributor.author-fmusphc | PEDRO ALVES LEMOS NETO | |
hcfmusp.description.articlenumber | 7 | |
hcfmusp.description.volume | 15 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 27063005 | |
hcfmusp.origem.scopus | 2-s2.0-84964547525 | |
hcfmusp.origem.wos | WOS:000386477500001 | |
hcfmusp.publisher.city | LONDON | |
hcfmusp.publisher.country | ENGLAND | |
hcfmusp.relation.reference | Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516 | |
hcfmusp.relation.reference | Diehl P, 2008, THROMB HAEMOSTASIS, V99, P711, DOI 10.1160/TH07-05-0334 | |
hcfmusp.relation.reference | Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003 | |
hcfmusp.relation.reference | Gardiner C., 2013, J EXTRACELL VESICLES, V2, DOI [10.3402/jev.v2i0.19671, DOI 10.3402/JEV.V2I0.19671] | |
hcfmusp.relation.reference | Horn P, 2015, EUROINTERVENTION, V10, P1456, DOI 10.4244/EIJY14M10_02 | |
hcfmusp.relation.reference | Hron G, 2007, THROMB HAEMOSTASIS, V97, P119, DOI 10.1160/TH06-03-0141 | |
hcfmusp.relation.reference | Huber J, 2002, ARTERIOSCL THROM VAS, V22, P101, DOI 10.1161/hq0102.101525 | |
hcfmusp.relation.reference | Jimenez JJ, 2003, BRIT J HAEMATOL, V123, P896, DOI 10.1046/j.1365-2141.2003.04716.x | |
hcfmusp.relation.reference | Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x | |
hcfmusp.relation.reference | McCabe JM, 2014, CATHETER CARDIO INTE, V83, P633, DOI 10.1002/ccd.25206 | |
hcfmusp.relation.reference | Mesri M, 1999, J BIOL CHEM, V274, P23111, DOI 10.1074/jbc.274.33.23111 | |
hcfmusp.relation.reference | Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6 | |
hcfmusp.relation.reference | Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764 | |
hcfmusp.relation.reference | Pfister SL, 2004, HYPERTENSION, V43, P428, DOI 10.1161/01.HYP.0000110906.77479.91 | |
hcfmusp.relation.reference | Toti F, 1996, BLOOD, V87, P1409 | |
hcfmusp.relation.reference | van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602 | |
hcfmusp.relation.reference | van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x | |
hcfmusp.relation.reference | Viera AJ, 2012, J AM SOC HYPERTENS, V6, P243, DOI 10.1016/j.jash.2012.06.003 | |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | 707a90ae-9138-40b4-a33c-9ff88d5348f7 | |
relation.isAuthorOfPublication | 68ea5951-1555-4036-b3fc-cb4e38c3d00e | |
relation.isAuthorOfPublication | 68dfcbfe-558c-42dc-9403-9e79e74b5775 | |
relation.isAuthorOfPublication | a970d450-bcd4-4662-94d6-ad1c6d043b3c | |
relation.isAuthorOfPublication | e5f6197a-e11d-4b47-af40-0542e85351f2 | |
relation.isAuthorOfPublication.latestForDiscovery | 707a90ae-9138-40b4-a33c-9ff88d5348f7 |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_MARCHINI_Endothelial_platelet_and_macrophage_microparticle_levels_do_not_2016.PDF
- Tamanho:
- 854.5 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)